Absence of cross-reactivity to myeloperoxidase of anti-thyroid microsomal antibodies in patients with autoimmune thyroid diseases

Citation
Ba. Freire et al., Absence of cross-reactivity to myeloperoxidase of anti-thyroid microsomal antibodies in patients with autoimmune thyroid diseases, AM J MED SC, 321(2), 2001, pp. 109-112
Citations number
23
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
ISSN journal
00029629 → ACNP
Volume
321
Issue
2
Year of publication
2001
Pages
109 - 112
Database
ISI
SICI code
0002-9629(200102)321:2<109:AOCTMO>2.0.ZU;2-#
Abstract
Background: Thyroperoxidase is the major antigen of the thyroid microsomal antibodies (TMA) detected in autoimmune thyroid diseases. Its amino acid se quence has 44% homology with myeloperoxidase (MPO), an enzyme present in th e primary granules of neutrophils and one of the major antineutrophil cytop lasmic antibodies (ANCA) antigens. The objective of the present study was t o investigate the presence of cross-reactivity to MPO of TMA. Methods: We s tudied sera from 51 patients with autoimmune thyroid diseases, all of them TMA-positive. The presence of ANCA was investigated by indirect immunofluor escence and by capture enzyme-linked immunosorbent assay. Results: ANCA wer e positive in 3.9% of the TMA-positive sera and none of them reacted with M PO. In contrast, the ANCA-positive sera revealed antielastase activity. Non e of the ANCA-positive cases presented clinical signs of vasculitis. Howeve r, these 2 patients had been on prolonged treatment with propylthiouracil. Conclusions: We conclude that there is no cross-reactivity to MPO of TMA in patients with autoimmune thyroid diseases, possibly because of difference in the spatial configuration of the immunodominant region. The presence of ANCA in patients with autoimmune thyroid diseases without evidence of vascu litis might result from propylthiouracil-induced polyclonal activation.